Cargando…
Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 and their co-expressed genes
Coronavirus disease-2019 (COVID-19) is a recent world pandemic disease that is caused by a newly discovered strain of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS- CoV-2). Patients with comorbidities are most vulnerable to this disease. Therefore, cancer patients are reported to be more...
Autores principales: | Mahmood, Tousif Bin, Chowdhury, Afrin Sultana, Hossain, Mohammad Uzzal, Hasan, Mehedee, Mizan, Shagufta, Aakil, Md. Mezbah-Ul-Islam, Hossan, Mohammad Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871107/ https://www.ncbi.nlm.nih.gov/pubmed/33585826 http://dx.doi.org/10.1016/j.crmicr.2021.100022 |
Ejemplares similares
-
A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia
por: Mahmood, Tousif Bin, et al.
Publicado: (2021) -
A systemic study on the vulnerability and fatality of prostate cancer patients towards COVID-19 through analysis of the TMPRSS2, CXCL10 and their co-expressed genes
por: Raza, Md. Thosif, et al.
Publicado: (2022) -
Missense mutations in spike protein of SARS‐CoV‐2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor
por: Mahmood, Tousif Bin, et al.
Publicado: (2022) -
CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria
por: Wilson, Nana O., et al.
Publicado: (2011) -
COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities
por: Aghili, Rokhsareh, et al.
Publicado: (2020)